|
Market Closed -
Nasdaq
16:00:00 2026-09-25 EDT
|
5-day change | 1st Jan Change | ||
| 2.480 USD | +2.06% |
|
-1.98% | -43.12% |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 111M | - | - | - | - | - |
| 72.26B | |||||
| 60.24B | |||||
| 27.73B | |||||
| 25.74B | - | ||||
| 24.75B | - |
- Stock Market
- Stocks
- GNLX Stock
- Charts Genelux Corporation
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
